Adhera Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ATRX Over the counter 2834 https://adherathera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adhera Therapeutics Inc

Adhera Therapeutics Announces Termination of Tender Offer for Preferred Stock - Sep 26th, 2019 8:19 pm
Adhera Therapeutics and Indegene Announce Next Gen Commercialization Partnership - Sep 10th, 2019 2:21 pm
Adhera and Allegis Pharma Announce Co-Promotion Agreement - Sep 6th, 2019 11:30 am
Adhera Therapeutics Announces Termination of Tender Offer for Warrants - Jul 2nd, 2019 8:15 pm
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer - Apr 4th, 2019 1:15 pm
Adhera Therapeutics' DyrctAxessTM Platform Helps 78% of Patients Adhere to PRESTALIA(R); Achieves Exceptionally High Level of Drug Adherence to an Antihypertensive Medication - Feb 6th, 2019 1:00 pm
Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update - Nov 21st, 2018 12:08 am